Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin

• DOI: 10.1016/j.jaci.2012.12.1566
• Publication Date: 2013-02-10T10:02:53Z
• Authors: Laurence Pellerin; Julie Henry; Chiung-Yueh Hsu; Stéfana Balica; Catherine Jean-De...; Marie-Claire Méchin; Britta Hansmann; Elke Rodriguez; Stefan Weindinger; Anne-Marie Schmitt; Guy Serre; Carle Paul; Michel Simon
• Keywords: Adult; Keratinocytes; Male; 0301 basic medicine; Interleukin-13; Blotting, Western; Calcium-Binding Proteins; Interleukin-17; Primary Cell Culture; S100 Proteins; Down-Regulation; Gene Expression; Filaggrin Proteins; Immunohistochemistry; Dermatitis, Atopic; 03 medical and health sciences; Intermediate Filament Proteins; Case-Control Studies; Humans; Female; Interleukin-4; Skin

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by a disturbed epidermal barrier. In a subset of patients, this is explained by nonsense mutations in the gene encoding filaggrin (FLG).We sought to evaluate the respective role of FLG mutations and proinflammatory cytokines and to assess the expression of FLG, hornerin (HRNR), and FLG2, 2 FLG-like proteins, which are involved in epidermal barrier functions, in normal skin and both lesional and nonlesional skin of patients with AD.An FLG-genotyped cohort of 73 adults with AD and 73 aged-matched control subjects was analyzed by using immunohistochemistry and immunoblotting. Normal primary human keratinocytes were differentiated in either the absence or presence of IL-4, IL-13, and IL-25.Compared with control subjects, FLG, HRNR, and FLG2 were detected at significantly lower levels in the skin of patients with AD, irrespective of their FLG genotype. The reduction was greater in lesional compared with nonlesional skin. In addition, the proFLG/FLG ratio was found to be higher in the skin of wild-type patients than in control subjects. Cytokine treatment of keratinocytes induced a dramatic reduction in FLG, FLG2, and HRNR expression both at the mRNA and protein levels.The stratum corneum of lesional but also clinically unaffected skin of adults with AD is abnormal, with reduced expression of FLG and FLG-like proteins. In addition to nonsense mutations, proinflammatory cytokines and some defects in the proFLG processing can contribute to the FLG downregulation. Our study suggests that skin inflammation reduces the expression of FLG-like proteins, contributing to the AD-related epidermal barrier dysfunction.